奎斯特诊疗（Quest Diagnostics，股票代码：DGX）今日盘中股价大涨5.44%，主要受益于公司公布的第一季度业绩超出市场预期。
根据公司最新发布的财报，奎斯特诊疗2025年第一季度调整后每股收益达2.21美元，高于分析师平均预期的2.15美元。季度营收同比增长12.1%，达到26.5亿美元，同样超过了分析师预估的26.3亿美元。这一强劲业绩主要得益于诊断测试需求的增加，特别是来自美国老年人群体对此前推迟的非紧急手术相关检查的需求。
值得注意的是，尽管季度业绩表现亮眼，奎斯特诊疗仍维持了其全年调整后每股收益预期，范围为9.55美元至9.80美元。这表明公司对未来业务发展保持谨慎乐观的态度。Leerink Partners分析师迈克尔·切尼（Michael Cherny）表示："我们并不期待公司业绩有什么大的起色，而是期待公司继续保持缓慢而稳定的业绩表现。"投资者对公司的稳健增长前景反应积极，推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.